🧫 Experiment Protocol
Exploratoryidiopathic pulmonary fibrosisbleomycin-treated cells and tissuesproposed
Comprehensive untargeted lipidomics analysis was conducted to investigate differential lipid species in pulmonary fibrosis models. The analysis identified lysophosphatidylcholines (LysoPCs) as key differential lipid species. This omics approach provided systematic characterization of lipid metabolite changes associated with pulmonary fibrosis development and progression, revealing specific lipid signatures that could serve as biomarkers or therapeutic targets.
PRIMARY OUTCOME
differential lipid species identification
EXPECTED OUTCOMES
Identification of dysregulated lipid metabolites
SUCCESS CRITERIA
Detection of significant differential lipid species
PROTOCOL
Mass spectrometry-based untargeted lipidomics analysis